Clinical Trial Detail

NCT ID NCT02409355
Title A Study of MPDL3280A Compared With Gemcitabine + Cisplatin or Carboplatin in Patients With Stage IV Squamous Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

lung non-small cell carcinoma

Therapies

Carboplatin

Cisplatin

Gemcitabine

Atezolizumab

Age Groups: adult

No variant requirements are available.